{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:09:55Z","timestamp":1794967795661,"version":"4.9.1"},"reference-count":50,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"1","license":[{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Kevin Mullin Memorial Fund"},{"name":"Kevin Mullin Memorial Fund"},{"name":"Brain Tumor Research for funds"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Commun"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p xml:lang=\"en\">\n                    Boron neutron capture therapy (BNCT) is a binary therapeutic modality based on the nuclear capture and fission reactions that occur when the stable isotope boron\u201010 is irradiated with neutrons to produce high\u2010energy alpha particles and recoiling lithium\u20107 nuclei. In this Commentary we will focus on a number of papers that were presented at a Symposium entitled \u201cCurrent Clinical Status of Boron Neutron Capture Therapy and Paths to the Future\u201d, which was held in September 2017 at the China National Convention Center in Beijing. Results were presented by clinicians from Japan, Finland, the United States, the China mainland and Taiwan, China who have been working in the multiple disciplines that are required for carrying out clinical BNCT. The main focus was on the treatment of patients with malignant brain tumors, recurrent tumors of the head and neck region, and cutaneous melanomas. The results obtained in treating these patients were reported in detail and, although most of the patients with brain tumors and head and neck cancer were not cured, there was evidence of some clinical efficacy. Although there are a number of problems that must be addressed, further clinical studies to evaluate the efficacy of BNCT are warranted. First, despite considerable effort by numerous investigators over the past 40 years, there still are only two boron\u2010containing drugs in clinical use,\n                    <jats:sc>l<\/jats:sc>\n                    \u2010boronophenylalanine (BPA) and sodium borocaptate (BSH). Therefore, until new and more effective boron delivery agents are developed, efforts should be directed to improving the dosing and delivery of BPA and BSH. Second, due to a variety of reasons, nuclear reactor\u2010based BNCT has ended except for its use in the China mainland and Taiwan. Therefore, the future of BNCT depends upon the results of the ongoing Phase II clinical trials that are being carried out in Japan and the soon to be initiated trials that will be carried out in Finland. If the results obtained from these clinical trials are sufficiently promising, then BNCT will have a clear path to the future, especially for patients with the therapeutically challenging malignancies that in the past have been treated with reactor\u2010based BNCT.\n                  <\/jats:p>","DOI":"10.1186\/s40880-018-0280-5","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T02:37:35Z","timestamp":1529030255000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":134,"title":["A realistic appraisal of boron neutron capture therapy as a cancer treatment modality"],"prefix":"10.34133","volume":"38","author":[{"given":"Rolf F.","family":"Barth","sequence":"first","affiliation":[{"name":"The Ohio State University","place":["Columbus, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizhu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Capture Technology Company, Ltd.","place":["Beijing, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[{"name":"Beijing Capture Technology Company, Ltd.","place":["Beijing, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1186\/1748\u2010717X\u20107\u2010146"},{"key":"e_1_3_2_3_2","first-page":"203","volume-title":"Boron science: new technologies & applications","author":"Sibrian\u2010Vazquez MV","year":"2011","unstructured":"Sibrian\u2010Vazquez MV, Vicente MGH. Boron tumor\u2010delivery for bnct: recent developments and perspectives. In: Hosmane NS, editor. Boron science: new technologies & applications. Boca Raton: CRC Press; 2011. 203\u2013232."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-3-642-31334-9_7","volume-title":"Neutron capture therapy","author":"Nakamura H","year":"2012","unstructured":"Nakamura H, Kirihata M. Boron compounds: new candidates for boron carriers in bnct. In: Sauerwein WAG, Wittig A, Moss R, Nakagawa Y, editors. Neutron capture therapy. Berlin: Springer; 2012. 99\u2013110."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1021\/cr941195u"},{"issue":"1","key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1023\/A:1023253309343","article-title":"A critical assessment of boron target compounds for boron neutron capture therapy","volume":"62","author":"Hawthorne MF","year":"2003","unstructured":"Hawthorne MF, Lee MW. A critical assessment of boron target compounds for boron neutron capture therapy. J NeuroOncol. 2003; 62 (1\u20132): 33\u201345.","journal-title":"J NeuroOncol."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","unstructured":"Barth RF Mi P Yang W. Boron delivery agents for neutron capture therapy of cancer. Cancer Commun. 2018; 10.1186\/s40880\u2010018\u20100299\u20107","DOI":"10.1186\/s40880-018-0299-7"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-3-642-84127-9_18","volume-title":"Glioma","author":"Hatanaka H","year":"1991","unstructured":"Hatanaka H. Boron neutron capture therapy for brain tumors. In: Karin ABMF, Laws E, editors. Glioma. Berlin: Springer; 1991. 233\u2013249."},{"issue":"1","key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1023234902479","article-title":"Clinical review of the japanese experience with boron neutron capture therapy and a proposed strategy using epithermal neutron beams","volume":"62","author":"Nakagawa Y","year":"2003","unstructured":"Nakagawa Y, Pooh K, Kobayashi T, et al. Clinical review of the japanese experience with boron neutron capture therapy and a proposed strategy using epithermal neutron beams. J NeuroOncol. 2003; 62 (1\u20132): 87\u201399.","journal-title":"J NeuroOncol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2005.103.6.1000"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11060\u2010008\u20109699\u2010x"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2011.02.008"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.09.057"},{"issue":"4","key":"e_1_3_2_14_2","first-page":"861","article-title":"Boron neutron capture therapy using epithermal neutrons for recurrent cancer in the oral cavity and cervical lymph node metastasis","volume":"18","author":"Ariyoshi Y","year":"2007","unstructured":"Ariyoshi Y, Miyatake S, Kimura Y, et al. Boron neutron capture therapy using epithermal neutrons for recurrent cancer in the oral cavity and cervical lymph node metastasis. Oncol Rep. 2007; 18 (4): 861\u2013866.","journal-title":"Oncol Rep."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijom.2008.12.010"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2009.03.019"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/hed.20418"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2004.05.059"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2009.03.103"},{"key":"e_1_3_2_20_2","unstructured":"Smick T. A compact neutron source designed for the hospital environment. https:\/\/www.neutrontherapeutics.com\/technology\/. 2017 (Personal Communication 03\/13\/2018)."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1269\/jrr.08043"},{"key":"e_1_3_2_22_2","first-page":"21","volume-title":"13th international congress on neutron capture therapy, a new option against cancer","author":"Kankaanranta L","year":"2008","unstructured":"Kankaanranta L, Sepp\u00e4l\u00e4 T, Koivunoro H, et al. Bpa\u2010based bnct in the treatment of glioblastoma multiforme: a dose escalation study. In: Zonta AA, Altieri S, Roveda L, Barth RF, editors. Abstracts of the 13th international congress on neutron capture therapy, a new option against cancer. 2008. p. 21."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.02.031"},{"key":"e_1_3_2_24_2","unstructured":"Chen Y\u2010W. Development of bnct for recurrent malignant gliomas: experience of the taipei veterans general hospital and tsing hua university. In: Symposium on current clinical status of boron neutron capture therapy and paths to the future. Beijing China September 8\u201310 2017."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1227\/01.neu.0000279727.90650.24"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11060\u2010017\u20102408\u2010x"},{"issue":"1","key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1023293006617","article-title":"Boron neutron capture therapy of brain tumors: clinical trials at the finnish facility using boronophenylalanine","volume":"62","author":"Joensuu H","year":"2003","unstructured":"Joensuu H, Kankaanranta L, Seppala T, et al. Boron neutron capture therapy of brain tumors: clinical trials at the finnish facility using boronophenylalanine. J NeuroOncol. 2003; 62 (1\u20132): 123\u2013134.","journal-title":"J NeuroOncol."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470\u20102045(09)70025\u20107"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043330"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600\u20100404.2009.01267.x"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/56953620"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2011.03.022"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.2015.1028369"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/978\u20103\u2010319\u201022536\u20104_16"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2014.11.019"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2015.11.010"},{"key":"e_1_3_2_37_2","unstructured":"Wang L\u2010W Liu Y\u2010WH Chou F\u2010I et al. Clinical trials for recurrent head and neck cancer at the Tsing\u2010Hua Open\u2010Pool Reactor (THOR) in Taiwan. Cancer Commun. 2018; 10.1186\/s40880\u2010018\u20100295\u2010y"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2013.11.002"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2011.01.006"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40349\u2010016\u20100055\u2010x"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11307\u2010013\u20100675\u20102"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(89)90567\u20109"},{"issue":"2","key":"e_1_3_2_43_2","first-page":"251","article-title":"First human clinical trial of melanoma neutron capture. Diagnosis and therapy","volume":"165","author":"Mishima Y","year":"1989","unstructured":"Mishima Y, Ichihashi M, Hatta S, et al. First human clinical trial of melanoma neutron capture. Diagnosis and therapy. Strahlentherapie und Onkologie. 1989; 165 (2\u20133): 251\u2013254.","journal-title":"Strahlentherapie und Onkologie"},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-9567-7","volume-title":"Cancer neutron capture therapy","author":"Mishima Y","year":"1996","unstructured":"Mishima Y. Selective thermal neutron capture therapy of cancer cells using their specific metabolic activities\u2014melanoma as prototype. In: Mishima Y, editor. Cancer neutron capture therapy. New York: Plenum Press; 1996."},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2015.07.049"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000\u20109604.2016.06.10"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03178777"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045\u2010017\u20100458\u20103"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.21037\/cco.2017.04.01"},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","unstructured":"Hiratsuka J Kamitani N Tanaka R et al. Boron neutron capture therapy for vulvar melanoma and genital extramammary Paget's disease with curative responses. Cancer Commun. 2018; 10.1186\/s40880\u2010018\u20100297\u20109","DOI":"10.1186\/s40880-018-0297-9"},{"key":"e_1_3_2_51_2","doi-asserted-by":"crossref","unstructured":"Barth RF Mi P Yons W. Boron delivery agents for neutron capture therapy of cancer. Cancer Commun. 2018; 10.1186\/s40880\u2010018\u20100299\u20107","DOI":"10.1186\/s40880-018-0299-7"}],"container-title":["Cancer Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40880-018-0280-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40880-018-0280-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1186%2Fs40880-018-0280-5","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40880-018-0280-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1186\/s40880-018-0280-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:56:30Z","timestamp":1773824190000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1186\/s40880-018-0280-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1186\/s40880-018-0280-5"],"URL":"https:\/\/doi.org\/10.1186\/s40880-018-0280-5","relation":{},"ISSN":["2523-3548"],"issn-type":[{"value":"2523-3548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,19]]},"assertion":[{"value":"2018-01-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"36"}}